- Danaher press release (NYSE:DHR): Q2 Non-GAAP EPS of $1.80 beats by $0.16.
- Revenue of $5.9B (+3.5% Y/Y) beats by $60M.
-
Third Quarter and Full Year 2025 Outlook
-
For the third quarter 2025, the Company anticipates that non-GAAP core revenue will grow low-single digits year-over-year.
For full year 2025, there is no change to the Company’s expectation that non-GAAP core revenue will grow approximately 3% year-over-year. The Company is also increasing its full year adjusted diluted net earnings per common share guidance to a range of $7.70 to $7.80 versus previous guidance of $7.60 to $7.75.
More on Danaher
- Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside
- Danaher: High Capex And Low Debt Despite Trump Legislation
- Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)
- Danaher Q2 2025 Earnings Preview
- Notable analyst calls this week: Tesla, Microsoft and Illumina among top picks